Guangdong Biolight Meditech Co., Ltd. (300246.SZ)
CNY 7.6
(-0.78%)
CNY 7.6
(-0.78%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 435.22 Million CNY | -6.84% |
| 2022 | 329.02 Million CNY | 27.55% |
| 2021 | 257.95 Million CNY | 24.1% |
| 2020 | 207.86 Million CNY | -7.97% |
| 2019 | 225.87 Million CNY | 9.66% |
| 2018 | 205.98 Million CNY | 21.0% |
| 2017 | 170.23 Million CNY | 8.2% |
| 2016 | 157.32 Million CNY | 33.93% |
| 2015 | 117.47 Million CNY | 22.88% |
| 2014 | 95.59 Million CNY | 15.47% |
| 2013 | 82.79 Million CNY | 44.21% |
| 2012 | 57.4 Million CNY | 27.6% |
| 2011 | 44.99 Million CNY | 25.44% |
| 2010 | 35.86 Million CNY | 30.71% |
| 2009 | 27.44 Million CNY | 31.21% |
| 2008 | 20.91 Million CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 76.41 Million CNY | -1.01% |
| 2024 Q2 | 75.88 Million CNY | -0.69% |
| 2024 Q3 | 71.25 Million CNY | 0.38% |
| 2023 Q4 | 77.18 Million CNY | 7.68% |
| 2023 Q1 | 87.81 Million CNY | 0.81% |
| 2023 Q2 | 69.81 Million CNY | -20.49% |
| 2023 FY | 306.5 Million CNY | -6.84% |
| 2023 Q3 | 71.68 Million CNY | 2.67% |
| 2022 FY | 329.02 Million CNY | 27.55% |
| 2022 Q3 | 79.84 Million CNY | -2.89% |
| 2022 Q1 | 79.85 Million CNY | -3.8% |
| 2022 Q2 | 82.21 Million CNY | 2.96% |
| 2022 Q4 | 87.1 Million CNY | 9.09% |
| 2021 Q2 | 54.58 Million CNY | 3.3% |
| 2021 Q1 | 52.84 Million CNY | 155.0% |
| 2021 Q3 | 67.5 Million CNY | 23.67% |
| 2021 Q4 | 83.01 Million CNY | 22.96% |
| 2021 FY | 257.95 Million CNY | 24.1% |
| 2020 FY | 207.86 Million CNY | -7.97% |
| 2020 Q4 | 20.72 Million CNY | -65.18% |
| 2020 Q3 | 59.5 Million CNY | -28.35% |
| 2020 Q2 | 83.05 Million CNY | 86.28% |
| 2020 Q1 | 44.58 Million CNY | -37.04% |
| 2019 Q4 | 70.81 Million CNY | 35.63% |
| 2019 FY | 225.87 Million CNY | 9.66% |
| 2019 Q1 | 47.09 Million CNY | -19.93% |
| 2019 Q2 | 55.76 Million CNY | 18.4% |
| 2019 Q3 | 52.2 Million CNY | -6.37% |
| 2018 Q3 | 50.34 Million CNY | -6.57% |
| 2018 Q2 | 53.88 Million CNY | 25.47% |
| 2018 Q4 | 58.81 Million CNY | 16.83% |
| 2018 FY | 205.98 Million CNY | 21.0% |
| 2018 Q1 | 42.94 Million CNY | -14.15% |
| 2017 Q4 | 50.02 Million CNY | 6.52% |
| 2017 FY | 170.23 Million CNY | 8.2% |
| 2017 Q1 | 37.87 Million CNY | -29.75% |
| 2017 Q3 | 46.95 Million CNY | 32.72% |
| 2017 Q2 | 35.38 Million CNY | -6.58% |
| 2016 Q2 | 33.81 Million CNY | 8.94% |
| 2016 FY | 157.32 Million CNY | 33.93% |
| 2016 Q1 | 31.03 Million CNY | -14.38% |
| 2016 Q4 | 53.9 Million CNY | 39.79% |
| 2016 Q3 | 38.56 Million CNY | 14.05% |
| 2015 Q2 | 27.96 Million CNY | 18.38% |
| 2015 Q4 | 36.25 Million CNY | 22.37% |
| 2015 Q3 | 29.62 Million CNY | 5.91% |
| 2015 FY | 117.47 Million CNY | 22.88% |
| 2015 Q1 | 23.62 Million CNY | -12.21% |
| 2014 Q2 | 22.11 Million CNY | -0.91% |
| 2014 Q3 | 24.23 Million CNY | 9.58% |
| 2014 Q4 | 26.91 Million CNY | 11.04% |
| 2014 FY | 95.59 Million CNY | 15.47% |
| 2014 Q1 | 22.32 Million CNY | -18.64% |
| 2013 Q1 | 17.22 Million CNY | -5.89% |
| 2013 Q3 | 19 Million CNY | -0.59% |
| 2013 Q4 | 27.43 Million CNY | 44.34% |
| 2013 FY | 82.79 Million CNY | 44.21% |
| 2013 Q2 | 19.12 Million CNY | 11.04% |
| 2012 Q1 | 13.72 Million CNY | -4.3% |
| 2012 Q4 | 18.29 Million CNY | 26.8% |
| 2012 Q3 | 14.43 Million CNY | 31.79% |
| 2012 FY | 57.4 Million CNY | 27.6% |
| 2012 Q2 | 10.95 Million CNY | -20.23% |
| 2011 Q1 | 10.75 Million CNY | -0.44% |
| 2011 FY | 44.99 Million CNY | 25.44% |
| 2011 Q2 | 8.69 Million CNY | -19.14% |
| 2011 Q4 | 14.34 Million CNY | 28.07% |
| 2011 Q3 | 11.2 Million CNY | 28.82% |
| 2010 Q3 | 8.95 Million CNY | 0.0% |
| 2010 Q4 | 10.8 Million CNY | 20.57% |
| 2010 FY | 35.86 Million CNY | 30.71% |
| 2009 FY | 27.44 Million CNY | 31.21% |
| 2008 FY | 20.91 Million CNY | 0.0% |